Equilibrium Psychotherapy

Drugs 101

,

Everything you were too afraid to ask

Drugs 101

Why a therapist would write about using drugs more safely, how drugs work in your brain, what each drug does and how long it lasts, why a pill is stronger and less predictable than it looks, which combinations cause the most emergencies, what an overdose looks like and what to do, the risks of pills from someone else’s prescription, when use starts to become a problem and what helps, and plain answers to the questions people rarely ask out loud

43 minute read  ·  9,637 words29 minute read  ·  6,610 words

Detailed explains the research and the reasons behind each point. Plain words gives the same main points in short, everyday language. Safety advice and emergency steps are the same in both.

Someone at a festival offers you half a pill and says it’s fine, they’ve already had one. A friend falls asleep on the couch after a party and starts snoring in a way that doesn’t sound right. Your roommate has ADHD tablets, and your exams start on Monday. If you’ve been in a moment like one of these, you know how fast it happens, and how little you usually have to go on.

The safest choice is not to use drugs at all. But if you’re going to, or someone you care about is, you deserve real information rather than a lecture. This article is about how to be less likely to get hurt: what each drug does, why strength is so hard to judge, which mixes cause the most emergencies, and what to do when something goes wrong. It’s also about the part that’s harder to talk about, which is how drugs affect your mind, and how to tell when using has started to cost you more than it gives.

Nobody reading this is being judged!! Maybe you’re curious, maybe you’re worried about yourself or a friend, maybe something happened last weekend that scared you. Whichever it is, you’re in the right place. If you’d like everything in plainer words, choose Plain words above.

If someone is unconscious, struggling to breathe or can’t be woken right now, call your local emergency number first: 112 across the European Union, 999 in the UK, 911 in the US and Canada, 000 in Australia. Then go straight to part six.

WHAT THIS ARTICLE COVERS · NINE PARTS

PART 1Why write about using more safely3 sections · 2 min1 min
PART 2How drugs work in your brain7 sections · 10 min3 min
PART 3What each drug does7 sections · 6 min4 min
PART 4Why one pill is never just one pill4 sections · 3 min2 min
PART 5What should never be mixed4 sections · 3 min2 min
PART 6If it goes wrong5 sections · 4 min
PART 7When the pills came from a prescription5 sections · 3 min2 min
PART 8Your mind, and when it becomes a problem5 sections · 5 min4 min

Part one of nine

Why write about using more safely

The starting point, and what harm reduction actually is

In plain words

Not using drugs is the safest choice, and saying no is a perfectly good answer. But if all you’ve ever heard is “don’t”, then the day you say yes, you’re left with a friend’s advice, a forum or a guess.

If you do use, it helps a lot to know what you’re taking, how much, what you’re mixing it with and what to do if something goes wrong. Knowing that makes you much less likely to get hurt, and you have every right to know it.

This is health information, not legal advice. Drug laws and services are very different from one country to the next.

This way of helping is called harm reduction. It means helping you stay safer without asking you to promise anything first. The World Health Organization recommends it, and so does the whole United Nations system.

Does talking about safer use make people use more? Where that’s been studied, it hasn’t been found. Handing out overdose medicine and clean needles hasn’t been found to lead to more drug use. Where something hasn’t been tested yet, this article says so.

About one adult in sixteen around the world used a drug in the past year, and most of them don’t have an addiction. Emergencies do not only happen to people with an addiction. A first try can be enough, or a batch that’s stronger than usual. In Europe, most drug deaths involve more than one substance.

The starting point

Most people who try a drug aren’t in crisis. They’re curious, or at a party, or exhausted, or just want one night off from their own head. Plenty of people say no, and that’s a perfectly good answer. But if all you’ve ever heard is “don’t”, then the day you say yes, your information comes from a friend, a forum or a guess.

That isn’t fair on you. Not using is still the safest choice. If you do use drugs, knowing what you’re taking, how much, what with, and what to do if it goes wrong makes you much less likely to be hurt, and you have every right to know it.

This is health information, not legal advice. Drug laws are very different from one country to the next, and so are the services this article mentions. When it names one, it says where it is.

What harm reduction means

This approach is called harm reduction. Harm reduction means meeting you where you are and helping you stay safer, without making you promise anything first. It includes things like sterile needles, a medicine that reverses an overdose, and treatment that doesn’t demand you stop using before you’re allowed any help.

It isn’t a fringe idea. The World Health Organization recommends it, and so does the whole United Nations system.

You might wonder whether talking this way encourages people to use drugs. Where that has been tested, it has not been found. Studies of handing out overdose medicine found no sign that it led to more drug use, and the same is true of needle programs. Where something hasn’t been tested yet, this article says so.

How common this is

If you’ve ever felt like the only one, you aren’t. The United Nations estimates that about one adult in every sixteen worldwide used a drug in the past year.

Most of them don’t have an addiction. UN figures suggest that roughly four in five people who use drugs don’t have what doctors call a drug use disorder, meaning use that has become a problem.

That’s exactly why the practical side matters. Emergencies do not only happen to people with an addiction. A first time, a stronger batch than usual or an unlucky mix can be enough. In Europe, most drug deaths involve more than one substance, which means a lot of them start with a decision that felt small at the time.

Part two of nine

How drugs work in your brain

Messengers, receptors, and the biology behind the risks

In plain words

Your brain runs on nerve cells that pass messages to each other. Inside a cell, a message is a tiny electrical pulse. But the cells don’t quite touch. To cross the tiny gap between them, the message turns into a chemical, called a messenger.

The messenger lands on the next cell in a docking spot shaped to fit it, a bit like a key in a lock. Then it gets cleared away, mostly by being pumped back into the cell that sent it. Every drug in this article works by getting in the middle of this handover.

A few messengers explain most of what drugs do. Dopamine helps you learn what’s worth doing again, and it drives wanting. Serotonin helps with mood, sleep, appetite and body heat (most of your body’s serotonin is actually in your gut, not your brain!). Noradrenaline keeps you alert and raises your heart rate and blood pressure. GABA is the brain’s main brake, and glutamate is its main accelerator.

Drugs get in the middle in different ways. Opioids copy the body’s own painkillers. MDMA makes the cell pour out extra messenger. Cocaine jams the pump, so messenger builds up in the gap. Naloxone, a medicine that reverses an opioid overdose, blocks the docking spot that opioids use. Alcohol and benzodiazepines make the brake work harder.

A small group of cells at the base of your brain keeps you breathing without you having to think about it. Drugs that slow you down all end up there, each by its own route. These are opioids, alcohol, benzodiazepines, GHB, and the nerve-pain medicines pregabalin and gabapentin.

That’s why two of them together slow your breathing so much more than either one alone, and why “I only had a little of each” doesn’t protect you.

Opioids also dull the urge to breathe, so someone can stop breathing without gasping. An overdose can look like deep sleep, snoring and all. With GHB, the gap between an amount that feels good and a dangerous one is small, and there’s no antidote.

Uppers like cocaine, amphetamines and MDMA raise noradrenaline, which is why cocaine can strain the heart of someone young and healthy. MDMA also pushes your body heat up. And it makes your body hold on to water, so drinking lots of water on it can drop the salt in your blood low enough for the brain to swell. How fast a drug reaches the brain matters too. The faster the rise, the stronger the pull to do it again, which is part of why smoking or injecting a drug tends to be harder to control than swallowing or snorting it.

MDMA releases a lot of serotonin at once. With some other drugs, serotonin can build up to a dangerous level. This is called serotonin syndrome, and in severe cases it can kill. The signs are shaking, stiff or twitching muscles, a racing heart, overheating and confusion.

The most dangerous partner for MDMA is an older type of antidepressant called MAOIs, and the painkiller tramadol is another. The common SSRI antidepressants mostly weaken MDMA instead, and then the risk is taking more to make up for it.

If someone takes a drug often, the brain pushes back, and the same amount does less. That’s tolerance. It fades fast after a break, often within days, so a usual amount can then be too much. With opioids, the body seems to get used to the high faster than to the effect on breathing. So needing more to feel the same can put someone closer to an overdose than they think.

Stopping alcohol or benzodiazepines suddenly after heavy regular use isn’t a test of willpower. It can cause seizures, and with alcohol, a severe kind of confusion. It needs a doctor. The same goes for GHB.

A lot of people feel low a few days after MDMA, and it passes. There’s no good evidence that a night on MDMA burns holes in your brain. Heavy, repeated use is linked to small problems with memory and attention, though other drugs and lost sleep make that hard to untangle. Animal studies at high doses do show damage to serotonin nerve endings.

Pick a drug in the figure below to see what it does between two brain cells.

How brain cells pass a message on

One drink makes you chatty. A few more and you’re swaying, and the next morning there’s a gap where the walk home should be. A painkiller after an operation takes the edge off, and a drug from the same family can stop someone breathing. It can look as if every drug has its own kind of magic. They don’t. They all work the same basic way, and once you can see it, a lot of the advice in this article makes much more sense.

Your brain runs on nerve cells, called neurons, and each one is wired to many others. Inside a cell, a message travels as a tiny electrical pulse that lasts about a thousandth of a second. But the cells don’t actually touch. Between one and the next there’s a gap, called a synapse, far too small to see under an ordinary microscope.

To get across the gap, the pulse turns into chemistry. The end of the sending cell holds tiny packets of chemical messengers, called neurotransmitters. When the pulse arrives, some of the packets empty into the gap. The messenger drifts across and lands on receptors on the next cell, which are docking spots shaped to fit it, a bit like a key fitting a lock.

Then the message has to be cleared away, or it would keep going. Most messengers are pumped back into the cell that sent them, to be used again, and some are broken down by enzymes. It all takes a split second, and it’s happening billions of times over in your head right now. Every drug in this article works by getting in the middle of that handover, at the packets, the gap, the docking spots or the pumps.

The messengers you’ve heard of

There are dozens of messengers, but a handful explain most of what drugs do. You’ve probably heard some of their names, and some of the myths that come with them.

  • Dopamine helps your brain learn what’s worth doing again, and drives motivation and wanting. It’s often called the pleasure chemical, but that isn’t really its job.
  • Serotonin does many jobs: mood, yes, but also sleep, appetite, body temperature and digestion (most of your body’s serotonin is actually in your gut, not your brain!). The idea that depression is simply a lack of serotonin hasn’t held up well, although serotonin is still part of the story.
  • Noradrenaline, called norepinephrine in the US, keeps you alert and raises your heart rate and blood pressure. It’s a big part of why stimulants are hard on the heart.
  • GABA is the brain’s main brake. It calms cells down and makes them less likely to fire.
  • Glutamate is the main accelerator. It excites cells, and it’s central to learning and memory.
  • Endorphins are the body’s own opioids. They ease pain and bring a sense of comfort (the famous runner’s high, it turns out, may have more to do with the next one on this list!).
  • Endocannabinoids are the body’s own cannabis-like messengers. They work backwards: the receiving cell releases them, and they tell the sending cell to send less. They turn the volume down in many circuits at once.

Where a drug acts matters as much as what it acts on. An opioid eases pain in one part of the brain and slows breathing in another. Alcohol slows the cerebellum, which handles balance, so you sway. It slows the hippocampus, which stores new memories, so there are gaps. And it slows the front of the brain, which weighs up consequences, so another drink seems like a great idea.

How a drug gets in the middle

A drug can get into that handover in a few different ways.

  • It copies a messenger. Some drugs are shaped enough like a natural messenger to fit its receptor and switch it on. Opioids copy endorphins. THC, the part of cannabis that gets you high, copies the body’s cannabis-like messengers, but only partly: it fits the lock without turning it all the way.
  • It makes more messenger pour out. MDMA and amphetamines, including speed and some ADHD medicines, get taken into the sending cell through its recycling pump and make the pump run backwards, pushing messenger out into the gap. MDMA does this mainly with serotonin.
  • It stops the messenger being cleared. Cocaine jams the pumps, so dopamine and noradrenaline stay in the gap and keep signaling. Methylphenidate, the ADHD medicine sold as Ritalin or Concerta, mainly works this way too, and so do the common SSRI antidepressants, for serotonin.
  • It blocks a receptor. Ketamine plugs the gate on one of glutamate’s receptors, which is part of why the world goes distant and numb. Naloxone sits on the opioid receptor without switching it on and takes the opioid’s place, which is how it reverses an overdose.
  • It turns up a signal that’s already there. Benzodiazepines don’t copy GABA. They sit on a second spot on the GABA receptor and make it respond more strongly whenever GABA arrives. Alcohol does something similar, among other things.
  • It turns down how much gets sent. Pregabalin and gabapentin work on the sending side and reduce how much messenger is released. Despite the name, they don’t act on GABA receptors at all.

Receptors also come in two broad kinds. Some are gates: when the messenger lands, the gate opens and the cell changes in a split second. GABA and glutamate receptors work like this, and so do the drugs that act on them, such as alcohol, benzodiazepines and ketamine, which change how awake, steady and responsive you are. Others work more like a dimmer switch. They set off a chain of steps inside the cell that turns a whole circuit up or down, more slowly. Opioids, cannabis and psychedelics act on these, which may be part of why they change mood, pain and perception rather than just making you more or less awake.

The lock and key picture is useful, but it’s a simplification. A key can fit without turning, which is how naloxone works. Some drugs use a second lock on the same door, like benzodiazepines. And the locks themselves change with regular use, which is where tolerance comes from.

Pick a drug in the figure below to see which messenger it works on, how, and the risk that follows. If you pick a downer, you can add a second one and see where the two meet.

Where two brain cells meet

Pick a drug to see what it does in the gapPick a drug to see what it does between two brain cells

sending cellpackets of messengerrecycling pumpthe gapreceptordocking spotreceiving cellreceptor on the sending sidedocking spot on the sending cellcalcium channelchannel on the sending cellcell turned downcell turned up
  • messenger
  • the drug
  • signal passing

A copy of the messenger sits in the receptor and switches it on.The drug looks enough like the messenger to fit its docking spot and switch it on.

A partial copy sits in a receptor on the sending side. It switches the receptor on only part way, and that turns down how much is released.The drug fits a docking spot on the sending cell and switches it on only part way, so the cell sends less.

The pump runs backwards, so messenger pours out into the gap.The pump runs backwards and pushes extra messenger out into the gap.

The pump is jammed, so messenger is not cleared and builds up in the gap.The pump is jammed, so the messenger isn’t cleared away and builds up in the gap.

The drug takes the receptor’s seat but does not switch it on, so the messenger cannot get in.The drug sits in the docking spot without switching it on, so the messenger can’t get in.

The drug plugs the open gate, so the signal cannot pass.The drug plugs the open gate, so the signal can’t get through.

The drug blocks this glutamate receptor, so the signal cannot pass.The drug blocks this docking spot for glutamate, the accelerator, so the signal can’t get through.

The drug sits on a second spot of the receptor, so the receptor responds more strongly whenever the messenger arrives.The drug sits on a second spot, so the docking spot reacts more strongly each time the messenger arrives.

The drug latches onto a channel on the sending side, so fewer packets are released.The drug grabs a channel on the sending cell, so fewer packets are sent.

Drugs do not all work the same way. Some copy a messenger at its receptor: opioids, GHB and GBL, LSD and magic mushrooms, and cannabis, which copies it only partly. MDMA and amphetamines make the pump run backwards, so more messenger is released. Cocaine and methylphenidate jam the pump, so messenger builds up. Ketamine, nitrous oxide and naloxone block a receptor. Alcohol and benzodiazepines turn up a signal that is already there, and pregabalin and gabapentin turn down how much is sent. Five of these slow you down by different routes and meet at the cells that keep you breathing, which is why mixing them is dangerous. The drawing is a simplification: most drugs act on more than one target.Drugs work in different ways. Some copy a messenger, some make more of it pour out, some stop it being cleared, some block its docking spot, and some make a signal stronger or weaker. The five downers here take different routes to the same place, the cells that keep you breathing, which is why mixing them is dangerous. The drawing is simplified, because most drugs act on more than one target.Sources: pharmacology reviews and NIDA, US, listed in the references.

Why downers add up

You never have to think about breathing, because a small group of cells in your brainstem, at the base of the brain, keeps the rhythm going for you. Your body also has an alarm that makes you want to breathe, the urge you feel when you’ve held your breath too long.

Opioids act on both. The breathing cells have opioid receptors, and when an opioid lands there, the rhythm slows. Opioids also dull the urge to breathe, so someone can slow right down and stop without gasping or looking distressed. That’s why an overdose can look like deep sleep, snoring and all, which part six explains.

The other downers take different routes to the same place. Alcohol and benzodiazepines turn up GABA, the brake. GHB copies GABA at a different receptor. Pregabalin and gabapentin turn down how much gets sent. Different doors, but they all lead to the same room: the cells that keep you breathing.

Benzodiazepines show this clearly. On their own they rarely stop someone breathing, because they can only boost the GABA that’s already there. Add an opioid or alcohol, and that limit stops protecting you. Each drug pushes on the same circuit from a different side, so “I only had a little of each” doesn’t hold up. The amounts add up in the same place. This is the biology behind the mixing checker in part five.

GHB has a problem of its own. The gap between an amount that feels good and an amount that’s dangerous is small, and there’s no antidote.

Heat, water and a racing heart

Stimulants work on the messengers that keep you alert. Cocaine, amphetamines and MDMA all raise noradrenaline, the same messenger your body uses when you’re frightened or exercising hard. Your heart beats faster, your blood vessels tighten and your blood pressure goes up. That’s why cocaine can strain the heart of someone young and healthy.

How fast a drug reaches the brain matters too. In one study of people who use cocaine, smoked cocaine blocked the dopamine pumps about as much as snorted cocaine did, but the high came on in under two minutes instead of around fifteen, and felt much stronger. The faster the rise, the stronger the pull to do it again, which is part of why smoking or injecting a drug tends to be harder to control than swallowing or snorting it.

MDMA adds two problems of its own, both run by the hypothalamus, a small area deep in the brain that controls body temperature and water. The drug pushes your temperature up, partly through noradrenaline, and in a hot room you can overheat. It also makes the body release a hormone that tells the kidneys to hold on to water. That’s how drinking lots of water on MDMA can drop the salt in your blood low enough for the brain to swell, which is called hyponatremia, and why part three says to sip, not gulp.

Then there’s serotonin. MDMA releases a lot of it at once. If something else stops serotonin being cleared or broken down at the same time, it can build up far beyond what either drug would cause alone. That’s serotonin syndrome: shaking, stiff or twitching muscles, a racing heart, overheating and confusion, and in severe cases it can kill.

The MAOI antidepressants, which stop serotonin being broken down, are the most dangerous partner for MDMA for exactly this reason. Tramadol, a painkiller that also slows serotonin clearing, is another. The common SSRIs mostly do something different with MDMA: they block the pump MDMA needs to get into the cell, which weakens it, and the risk becomes taking more to make up for it.

Why the same amount stops working

Your brain keeps itself in balance. If a drug pushes a system the same way day after day, the brain pushes back. It can make receptors less responsive, pull some of them inside the cell, or turn up the system that works the other way. That push-back is tolerance, and it’s why the same amount does less.

It isn’t as simple as “your receptors are wrecked”. Most of these changes reverse. In one brain-scan study of people who smoked cannabis every day, their cannabis receptors were reduced, and after about four weeks without it they were back to normal.

With opioids there’s an extra trap. Tolerance to the high seems to build faster than tolerance to the effect on breathing. So someone who needs more to feel the same can be closer to an overdose than they realize.

Tolerance also fades, often within days, much faster than most people expect. Your body readjusts, but your sense of what “your usual” is doesn’t change with it. That’s why part seven warns that your usual amount can be too much after a break.

Withdrawal is the same push-back, seen from the other side. When the drug is gone, the brain’s adjustments are still there, with nothing to push against. With alcohol and benzodiazepines, that’s dangerous. Months of a boosted brake leave the brain with its own brake turned down and its accelerator turned up. Take the drug away suddenly and the accelerator runs unopposed, which can cause seizures and, with alcohol, a severe state of confusion called delirium tremens. Stopping alcohol or benzodiazepines suddenly after heavy regular use isn’t a test of willpower. It needs a doctor. The same goes for GHB.

Regular use changes something else too, which is what the brain treats as important. The pull toward a drug can keep growing even as the enjoyment fades. Our article on dopamine explains why.

The day after, and the holes in your brain

A lot of people feel low a few days after taking MDMA, often midweek after a weekend. That dip seems to be real: small studies have found people’s mood dropping a few days after they used it. The usual explanation is that MDMA empties the brain’s serotonin stores for a while. That’s plausible, but it hasn’t been proven, and lost sleep, alcohol and a long weekend probably play a part too. It passes, and it’s one reason drug services suggest leaving a long gap between uses.

You may also have heard that MDMA burns holes in your brain. Part of that story goes back to a 2002 study in monkeys that made headlines around the world. A year later it was retracted: most of the animals had been given methamphetamine instead of MDMA, because of a mislabeled bottle. There’s no good evidence that a night on MDMA leaves holes in anyone’s brain. Heavy, repeated use is linked to small problems with memory and attention, though it’s hard to separate those from other drugs and lost sleep, and animal studies at high doses do show damage to serotonin nerve endings.

Part three of nine

What each drug does

When it starts, how long it lasts, and what trips people up

In plain words

The same drug can feel mild one night and too much the next. How it’s taken matters. Smoked cannabis kicks in within minutes, but the same amount eaten can take hours. Strength matters too, and you usually can’t know it. So do your body, your sleep, what you’ve eaten and anything else in your system. The figure below shows when each drug usually starts and how long it lasts.

A common mistake is about waiting. Someone eats an edible, feels nothing after an hour and takes another, and then both kick in at once. Eaten cannabis can take up to two hours to start and up to four to reach its strongest. That’s why the Australian drug service warns that an edible can still be building up 4 hours later. Pills can be slow too. MDMA can take up to an hour to start, and the same trap applies. Feeling nothing yet may just mean it hasn’t kicked in.

Edibles look like candy. In Canada, more young children ended up in the hospital after eating cannabis by accident once edibles went on sale. Keep them where a child can’t reach.

Cannabis is much stronger on average than it was a few decades ago. Heavy use of strong cannabis is linked to a higher risk of psychosis, which means losing touch with what’s real. Canada’s guidelines say not to drive for at least 6 hours after using. They also say that people with a close family history of psychosis shouldn’t use it at all. Starting later in life is also safer than starting young.

MDMA, also called ecstasy, makes you hotter, and dancing for hours in a hot room adds to it. Drug services say breaks somewhere cooler help, even when someone doesn’t feel hot. The Australian service notes that the risk goes up on warm days, above about 25℃, or 77℉.

Drinking too much water on MDMA can be as dangerous as drinking too little. The drug makes the body hold on to water, and the salt in the blood can drop so low that the brain swells. It’s rare, but it has killed people, and women seem to be at higher risk. So sip, don’t gulp! FRANK, the UK’s drug advice service, says to “sip no more than a pint of water or non-alcoholic drink every hour”.

Feeling flat for a day or several after MDMA is common (cue New Order’s Blue Monday), and it’s the drug wearing off. The Australian service advises a long break between uses.

Cocaine works within minutes and the high is short, so the urge to take more comes back fast. It’s hard on the heart. Even healthy young people can have a seizure, a heart attack or a stroke on it, so “I’m young and fit” doesn’t protect you. Chest pain on cocaine sends many people to the emergency room, and it’s always worth getting checked rather than hoping it passes. Sharing a straw can pass on infections such as hepatitis C and HIV. Use your own, and not a rolled-up banknote, which can cut the inside of your nose (I know, it’s less cool).

Ketamine makes you feel cut off from your body and what’s around you. A larger amount can leave someone unable to move or speak for a while. Most of the danger comes from the numbness. People hurt themselves without feeling it, fall, or choke if they vomit while they can’t move. The risk is much higher with alcohol or other drugs that slow you down. If a friend on ketamine is asleep or can’t move, put them on their side.

If you use it regularly and it’s started to hurt when you pee, you need to go all the time, or you’ve seen blood, please don’t be embarrassed to see a doctor. It can feel like a urine infection that won’t clear, but it’s damage to the bladder, and it can get serious enough to need surgery. It’s a known problem, and telling them you use ketamine helps them help you.

LSD can last up to 12 hours and mushrooms up to around 6, and once a trip starts you can’t stop it early. Drug services say a friend who stays sober and stays the whole time, called a trip sitter, is one of the most effective ways to stay safe. They also advise against taking psychedelics when someone is already feeling low.

A frightening trip isn’t the same as an overdose, and it usually passes as the drug wears off. If a friend is panicking, you don’t need to fix it. Take them somewhere quiet, away from crowds, lights and noise, help them breathe slowly, and stay. A calm voice helps. Most deaths linked to LSD are accidents, such as falls or car crashes, which is why a familiar place away from roads and water is safer.

Why the same drug can feel so different

You may have noticed this already: the same drug can feel mild one night and overwhelming the next. How it’s taken makes a big difference. Smoked cannabis is felt within minutes, but the same amount eaten can take hours. Strength matters too, and you usually can’t know it. So do your body, your sleep, what you’ve eaten and what else is in your system.

The figure below shows what drug advice services say about each drug, mainly FRANK in the UK and the Alcohol and Drug Foundation in Australia. Pick the one you’re wondering about to see when it usually starts, how long it lasts, its main danger and the step that makes it safer.

What to expect

When each drug starts, and how long it lasts

Cannabis, smoked

Also called weedgrassskunkhashpot

FRANK, UK

Starts 1 to 2 minutesLasts 40 minutes to 1 hour

Main danger
Anxiety or paranoia, and with heavy use of strong cannabis, a higher risk of psychosis
Safer step
Choose less strong products, keep use occasional, and do not drive for at least 6 hours (Lower-Risk Cannabis Use Guidelines)
Get help if
Chest pain, an irregular heartbeat, trouble breathing, or anxiety and paranoia that last for hours or days

Cannabis, eaten

Also called edibles

Alcohol and Drug Foundation, Australia

Starts 30 minutes to 2 hoursStrongest 1 to 4 hoursLasts not given

Main danger
Taking more because nothing seems to be happening, and then feeling both amounts at once
Safer step
The same service advises you to wait at least 4 hours before deciding whether to take more. Keep edibles away from children
Get help if
Chest pain, an irregular heartbeat, trouble breathing, hallucinations or paranoia

LSD

Also called acidblottertabtrips

FRANK, UK

Starts 20 minutes to 2 hoursLasts 6 to 12 hours

Alcohol and Drug Foundation, Australia

Starts 20 to 90 minutesLasts around 8 to 12 hours

Main danger
A frightening trip, accidents while confused, and psychosis in people who are vulnerable to it. Never with lithium
Safer step
A safe place, people you trust and a sober trip sitter. Not when you already feel low or depressed
Get help if
Intense panic, paranoia, a seizure, chest pain, or hearing and seeing things that do not stop

Magic mushrooms

Also called shroomsmushiesliberty caps

FRANK, UK

Starts can take more than 30 minutesLasts up to 5 hours

Alcohol and Drug Foundation, Australia

Starts not givenLasts 4 to 6 hours

Main danger
Picking a poisonous mushroom by mistake, which FRANK calls the biggest danger. Strength varies a lot
Safer step
If there is any doubt about what a mushroom is, do not take it. Crew advises waiting at least two hours before taking more
Get help if
If a poisonous mushroom may have been eaten, contact a poisons center at once, before any symptoms

Ketamine

Also called kketspecial k

FRANK, UK (snorted)

Starts about 15 minutesLasts 30 minutes to an hour

Crew, Scotland

Starts within 5 minutesLasts 1 to 2 hours

Main danger
Injuries you do not feel, choking on vomit when unable to move, and bladder damage with regular use
Safer step
Never with alcohol or other downers. Crew advises a minimum of 2 hours before each dose, and anyone who cannot move goes on their side
Get help if
Cannot be woken with a shout or a shake, snoring or raspy breathing, or pain or blood when you pee

MDMA

Also called emandymollypillsmd

FRANK, UK

Starts 20 to 30 minutes on averageLasts 2 to 4 hours

Alcohol and Drug Foundation, Australia

Starts about 20 minutes to an hourLasts not given

Main danger
Overheating while dancing, drinking too much water, and pills far stronger than a single dose
Safer step
Take part of a pill and wait. Take breaks to cool down, and sip water rather than gulping it
Get help if
Very high body temperature, confusion, rigid muscles, a racing heart, chest pain or a seizure

Cocaine

Also called cokecharlieblowsnowcrack

FRANK, UK (snorted)

Starts around 5 to 30 minutesLasts around 20 to 30 minutes (the high)

NIDA, US

Starts not givenLasts 15 to 30 minutes (the high)

Main danger
Strain on the heart, including in young, healthy people, and the urge to keep taking more
Safer step
Your own straw, never a shared one or a banknote. Avoid alcohol and other stimulants
Get help if
Chest pain, including in the arm, back, neck or jaw, a racing heart, a seizure, or severe agitation

ADHD medicine

NHS, UK

Starts 30 to 60 minutesLasts not given

Alcohol and Drug Foundation, Australia (short-acting)

Starts not givenLasts around 4 to 6 hours

Alcohol and Drug Foundation, Australia (long-acting)

Starts not givenLasts about 8 to 12 hours

Main danger
A racing heart and high blood pressure in someone who was never checked for heart problems, and lost sleep
Safer step
Start with a small amount and wait, do not mix it with alcohol, and tell someone what you have taken
Get help if
Chest pain or tightness, a fast irregular heartbeat, a seizure, or weakness in the face or limbs

Heroin and other opioids

Also called browngearsmackh

Alcohol and Drug Foundation, Australia

Starts not givenLasts 3 to 5 hours (main effects)

Main danger
Breathing slows or stops. Fentanyl and nitazenes can be hidden in heroin, fake pills and other drugs
Safer step
Never use alone, carry naloxone and tell people where it is, and never mix with other downers
Get help if
Cannot be woken, slow or noisy breathing, pinpoint pupils, or blue or gray lips. Give naloxone and call

Benzodiazepines

Also called benzosbarsxansvalliesblues

FRANK, UK

Starts about 30 minutesLasts around 1 to 4 hours, depending on the type

Main danger
With opioids or alcohol, breathing can stop. Street versions are unpredictable, and stopping suddenly after regular use can cause seizures
Safer step
Never with alcohol or opioids. FRANK advises trying half a pill of a street benzo and waiting at least an hour
Get help if
Very heavy sleepiness, slow shallow breathing, or cannot be woken

GHB and GBL

Also called geebsgblliquid ecstasy

Alcohol and Drug Foundation, Australia

Starts 10 to 15 minutesStrongest 30 to 60 minutesLasts 1.5 to 4 hours

FRANK, UK

Starts 10 minutes to an hourLasts not given

Main danger
A very small gap between the amount people want and a severe overdose, and much worse with alcohol
Safer step
Never with alcohol or other downers. Wait at least two hours before any more, and do not use alone
Get help if
Cannot be woken, slow or abnormal breathing, vomiting or a seizure

Nitrous oxide

Also called laughing gasballoonsnozchargers

FRANK, UK

Starts straight awayLasts 1 to 2 minutes on average

Alcohol and Drug Foundation, Australia

Starts straight awayLasts a few minutes

Main danger
Fainting and lack of oxygen, and nerve damage with heavy, regular use
Safer step
Sit down, never alone, fresh air and breaks, nothing over your head, and no alcohol with it
Get help if
A seizure, chest pain, loss of consciousness, or tingling and numbness after regular use
Timings as two national services give them, FRANK in the UK and the Alcohol and Drug Foundation in Australia, with other sources named where they are used. They are ranges, not promises: how a drug is taken, how strong it is, your body and anything else you have taken all change them. The slowest to start, eaten cannabis, is the one most often taken twice by mistake.

The slow ones trip people up

A common mistake has nothing to do with strength. It’s about waiting.

Edibles are the classic example. You eat one, feel nothing after an hour, and start to think it’s a dud, so you take another. Then both kick in at once. If that’s happened to you, it isn’t because you were careless. Eaten cannabis can take up to two hours to start and up to four to peak, which is why the Australian service says to wait at least 4 hours before deciding whether to take more.

Edibles also look like candy. In Canada, more young children ended up in the hospital after eating cannabis by accident once edibles went on sale. If there are any at home, keep them where a child can’t reach.

Pills can be slow too. MDMA can take up to an hour to start, and the same trap applies: the second half of a pill, taken because the first seemed to do nothing, lands on top of it.

WHAT HELPS

  • Decide how much you’ll take before you start, while your head is clear.
  • Set a timer on your phone, and don’t take more until it goes off.
  • If you’re not sure it has kicked in, assume it hasn’t finished kicking in.

Cannabis is stronger than it used to be

If cannabis hits you harder than you remember, you’re not imagining it. It’s much stronger, on average, than it was a few decades ago: THC, the part that gets you high, has gone up, while CBD, which may soften some of its effects, has stayed about the same.

With heavy use, stronger cannabis is linked to a higher risk of psychosispsychosisLosing touch with what is real: hearing or seeing things that are not there, or holding frightening beliefs that other people do not share. Part eight explains who is most at risk., which part eight explains. Canada’s lower-risk guidelines suggest choosing milder products, using only occasionally, and not driving for at least 6 hours afterwards.

The same guidelines say people with a close family history of psychosis should not use it at all. Starting later in life is also safer than starting young.

MDMA: heat, water and the day after

MDMA, also called ecstasy or molly, usually lasts a few hours. The two physical dangers are heat and water.

MDMA makes you hotter, and dancing for hours in a hot room makes you hotter still. The Australian service notes that the risk goes up on warm days, above about 25℃, or 77℉.

Water is where people can go wrong the other way, often while trying to be careful. Drinking too much water on MDMA can be as dangerous as drinking too little. The drug makes the body hold on to water, and the salt in the blood can drop so low that the brain swells. It’s rare, but it has killed people, and women seem to be at higher risk. So sip, don’t gulp! FRANK in the UK says to “sip no more than a pint of water or non-alcoholic drink every hour”.

The day after has its own low. Lots of people feel flat and low for a day or several, which is called a comedown (cue New Order’s Blue Monday). It’s the drug wearing off, not a sign that something is wrong with you. The Australian service suggests leaving one to three months before you use MDMA again.

WHAT HELPS

  • Take breaks from dancing, somewhere cooler, even when you don’t feel hot.
  • Sip water or a soft drink rather than drinking lots at once.
  • Plan an easy next day, with food, sleep and people you like.

Cocaine and the heart

Snorted cocaine works within minutes, and the high is short, often around half an hour. That’s part of what makes it hard: the urge to take more comes back fast, and one line can turn into a whole night of them before you’ve really decided anything.

It’s hard on the heart. Even healthy young people can have a seizure, a heart attack or a stroke on it, so “I’m young and fit” doesn’t protect you. Chest pain on cocaine sends many people to the emergency room, and it’s always worth getting checked rather than hoping it passes.

Sharing a straw can pass on infections such as hepatitis C and HIV. Use your own, and not a rolled-up banknote, which can cut the inside of your nose (I know, it’s less cool).

Ketamine: numb, and then some

Ketamine makes you feel detached from your body and your surroundings. Take more and you may not be able to move or speak for a while. People call this a k-hole, and it can be frightening, even if you’ve been before.

Most of the danger comes from the numbness. People hurt themselves without feeling it, fall, or choke if they vomit while they can’t move. The risk is much higher with alcohol or other drugs that slow you down. If a friend on ketamine is asleep or can’t move, put them on their side.

If you use it regularly and it’s started to hurt when you pee, you need to go all the time, or you’ve seen blood, please don’t be embarrassed to see a doctor. It feels like a urine infection that won’t clear, but it’s the bladder being damaged, and it can become serious enough to need surgery. It’s a known problem, and telling them you use ketamine helps them help you. Feeling low for a few days afterwards is also common.

Psychedelics and why the setting matters

LSD and magic mushrooms change how you see, hear and think. LSD can last up to 12 hours, and mushrooms up to around 6. Once it starts, you can’t make it stop early, so where you are and who you’re with matter a lot.

Drug advice services say that having a trip sitter is one of the most effective ways to stay safe on psychedelics. A trip sitter is a friend who stays sober and stays with you. They also advise against taking psychedelics when you’re already feeling low.

A frightening trip isn’t the same as an overdose, and it usually passes as the drug wears off. If a friend is panicking, you don’t need to fix it. Take them somewhere quiet, away from crowds, lights and noise, help them breathe slowly, and stay. A calm voice helps.

Most of the physical danger comes from what people do while tripping, and the deaths linked to LSD are mostly accidents, such as falls or car crashes.

WHAT HELPS

  • Choose a safe place you know, away from roads and water.
  • Have a sober friend there for the whole trip.
  • If you’re already feeling low, give it a miss that day.

Part four of nine

Why one pill is never just one pill

Strength, fake medicines, hidden opioids and what testing can tell you

In plain words

Most of us think a pill is one dose. It usually isn’t. In Europe, the average ecstasy pill roughly doubled in strength between 2011 and 2019, and much stronger ones are still around. Two pills with the same logo can be completely different, and online reports about a logo can’t tell you about the pill in your hand.

Most ecstasy tested in Europe turns out to be pure MDMA, so the bigger danger now is strength. A pure pill can still be far too strong.

That’s why drug advice services all warn people to be careful with strength. The safest amount is always less than people think. UK and Australian services warn against taking more before the first has had time to kick in.

This article gives no doses on purpose. Nobody knows what’s in street drugs or how strong they are, so a number would only give false confidence.

Fake medicines look exactly like real painkillers, anxiety pills or ADHD pills, but they can contain something much stronger. Any medicine that didn’t come from a pharmacy with your name on the label is an unknown drug, however real it looks. That includes pills bought online, and pills from a friend you trust.

Fentanyl is a lab-made opioid, much stronger than heroin. In North America it turns up in heroin, in fake pills and sometimes in other drugs, and in parts of the US and Canada it is often mixed with animal sedatives such as xylazine or medetomidine. Naloxone doesn’t reverse those sedatives, but give it anyway, because the opioid is almost always there too.

In Europe a newer group called nitazenes is spreading, and some are hundreds of times stronger than heroin. People who don’t usually take opioids are most at risk, because their bodies aren’t used to them at all. A line of cocaine or a pill with a hidden opioid in it can stop someone breathing, even if they’ve taken the same thing before without a problem.

If opioids could be in what you have, don’t use alone. Keep naloxone, a medicine that reverses an opioid overdose, nearby, and make sure your friends know where it is. Part six explains how it works and where to get it. A drug-checking service can also help, where there’s one nearby.

Drug checking means handing a small sample to a service that tests what’s in it. Some countries have these services and many don’t. If a test finds something dangerous, listen to it, even though you’ve paid and your friends are waiting.

Fentanyl test strips, found mostly in North America, can give false alarms and miss some types of fentanyl. Nitazenes need separate strips, and those miss some too. No study has yet shown that the strips prevent overdoses. A test can tell you to be more careful. It can never tell you that something is safe.

Stronger than people expect

Most of us assume a pill is one dose. It usually isn’t. In Europe, the average ecstasy pill roughly doubled in strength between 2011 and 2019, and much stronger ones are still around. A UK drug-checking charity puts it simply: “A single pill is likely to be more than a single dose.“

What a pill looks like tells you almost nothing. Two pills with the same logo can be completely different in strength and content. Online reports about a logo don’t help either, because your pill may not be the one someone else tested.

In Europe, most ecstasy that gets tested turns out to be pure MDMA. The bigger danger now is strength, not what it was cut with. A pure pill can still be far too strong.

That’s why the drug advice services all say the same thing: start low and wait. FRANK suggests taking “half or even a quarter of the pill” and waiting for it to kick in before taking any more. UK and Australian services suggest waiting at least 90 minutes to two hours before taking more.

You won’t find doses in this article, and that’s on purpose. With street drugs, nobody really knows what’s in them or how strong they are, so a number would only give you false confidence. The safest amount is always less than you think, and waiting is the rule.

It can feel awkward to take less than your friends, or to wait while they don’t. That’s fine. Taking too little is a much easier mistake to live with than taking too much!

Fake medicines look real

Fake medicines are a growing danger, and they’re very convincing. They look exactly like real painkillers, anxiety pills such as Xanax, or ADHD pills such as Adderall, but they can contain something much stronger.

Because they look real, they feel safe, and that’s the trap. The US Drug Enforcement Administration warns: “Never trust your own eyes to determine if a pill is legitimate.”

So treat it this way: a medicine that didn’t come from a pharmacy, with your name on the label, is an unknown drug, however familiar it looks. That includes pills bought online and pills from a friend who swears they’re real, even a friend you trust.

Fentanyl and the new synthetic opioids

Fentanyl is a lab-made opioid, much stronger than heroin. In North America it now turns up in heroin, in fake pills and sometimes in other drugs, and in parts of the US and Canada it is often mixed with animal sedatives such as xylazine or medetomidine. Naloxone doesn’t reverse those sedatives, but give it anyway, because the opioid is almost always there too. In Europe a newer group, the nitazenes, is spreading, and some are hundreds of times stronger than heroin.

The risk is greatest for people who don’t normally take opioidsopioidsA family of drugs that relieve pain and slow breathing, including heroin, fentanyl and painkillers such as codeine, tramadol and oxycodone. Too much can stop someone breathing., because their bodies have no tolerance at all. A line of cocaine or a pill with a hidden opioid in it can stop someone breathing, even if they’ve taken the same thing before without a problem.

WHAT HELPS, IF OPIOIDS COULD BE IN WHAT YOU HAVE

  • Start with a very small amount.
  • Don’t use alone.
  • Keep naloxonenaloxoneA medicine that reverses an opioid overdose for long enough to get help, given as a nasal spray or an injection. Part six explains how to use it and where to get it. nearby, and make sure your friends know where it is. Part six explains it.
  • Use a drug-checking service if there’s one near you.

Testing your drugs: what it can and cannot tell you

Drug checking means handing a small sample to a service that tests what’s in it, and often how strong it is. Some countries have these services and many don’t, so it’s worth finding out what exists where you live.

A test only helps if you act on it. In studies, an unexpected or dangerous result changes what many people do, but not everyone throws the drug away. It’s understandable, because you’ve paid for it and your friends are waiting, but a bad result is exactly the moment to listen.

Fentanyl test strips are small paper strips, mostly available in North America, that show whether a sample contains fentanyl. They’re cheap, quick and accurate in the lab. But they can give false alarms, they miss some types of fentanyl, and nitazenes need separate strips of their own, which also miss some. No study has yet shown that the strips prevent overdoses.

A test can tell you to be more careful. It can never tell you that something is safe.

Part five of nine

What should never be mixed

The combinations behind most emergencies

In plain words

Most drug emergencies involve more than one thing. A few drinks at dinner, something at the party, then a pill to help you sleep. Each one alone might have been fine. Together, they can stop someone breathing.

The biggest danger in this whole article is taking two or more drugs that slow the body down. These are opioids, benzodiazepines, alcohol, GHB, and the nerve-pain medicines pregabalin and gabapentin. Each one slows your breathing, and together the effect adds up, sometimes by more than you’d expect. With opioids and benzodiazepines, the risk is highest in the first days of taking them together. Alcohol counts, even though it’s legal, and so do medicines from a pharmacy. If you’ve been drinking, the pill that “helps you sleep” is the one to skip.

Two uppers together, like cocaine with MDMA or speed, strain the heart and make anxiety and paranoia more likely. Cocaine makes you feel less drunk than you are, so people drink more. The two also combine in your body into a new substance that lasts longer than cocaine. Research hasn’t settled how harmful it is, but the advice is still to avoid the mix.

Cocaine with an opioid is dangerous too. The cocaine hides how drowsy the opioid has made someone. When the cocaine wears off first, the opioid is still working, and breathing can slow or stop.

If you take a prescribed medicine, how it mixes with a night out depends on which one. The most common antidepressants, called SSRIs, mostly weaken MDMA, and the danger is taking more to chase a high that isn’t coming. An older type of antidepressant, the MAOIs, is genuinely dangerous with MDMA, and people have died. MAOIs stay in the body for up to two weeks after you stop.

Tramadol, a prescription painkiller, can cause seizures, and the risk goes up with MDMA, cocaine or antidepressants. Lithium, used for bipolar disorder, has been linked to seizures with LSD or magic mushrooms.

A pharmacist can tell you how your medicine mixes with other drugs, and it’s an ordinary question to ask. Please don’t stop your own medicine to make room for a night out.

The checker below lets you look up two drugs together. If a pair isn’t on it, that doesn’t mean it’s safe.

Most emergencies involve more than one thing

Picture a long night: a few drinks at dinner, something at the party, and at three in the morning a pill that someone says will help you sleep. None of it feels like a big decision. Each one alone might have been fine. Together, they can stop someone breathing.

This pattern is behind a large share of drug deaths. It’s also one of the easiest things to change, because it doesn’t depend on what’s in the drug. It depends on what you take together. The figure below lets you check two drugs against each other. If a pair isn’t on it, that doesn’t mean it’s safe.

Don’t mix

Check two drugs against each other

Dangerous

Both slow breathing, and together the effect adds up. The risk is highest in the first days of taking them together.

Source: US FDA; Hernandez 2018

Every pair on this chart
  • Dangerousopioids (heroin, fentanyl, painkillers) with benzodiazepines
  • Dangerousopioids (heroin, fentanyl, painkillers) with alcohol
  • Dangerousopioids (heroin, fentanyl, painkillers) with GHB or GBL
  • Dangerousopioids (heroin, fentanyl, painkillers) with pregabalin or gabapentin
  • Dangerousopioids (heroin, fentanyl, painkillers) with ketamine
  • Dangerousopioids (heroin, fentanyl, painkillers) with cocaine
  • Dangerousbenzodiazepines with alcohol
  • Dangerousbenzodiazepines with GHB or GBL
  • Dangerousbenzodiazepines with ketamine
  • DangerousGHB or GBL with alcohol
  • Dangerousketamine with alcohol
  • DangerousMDMA with MAOI antidepressants
  • Dangeroustramadol with MDMA
  • Dangeroustramadol with cocaine
  • Dangeroustramadol with amphetamines or ADHD medicine
  • Dangeroustramadol with SSRI antidepressants
  • DangerousLSD or magic mushrooms with lithium
  • Take extra carecocaine with alcohol
  • Take extra carecocaine with MDMA
  • Take extra carecocaine with amphetamines or ADHD medicine
  • Take extra careMDMA with amphetamines or ADHD medicine
  • Take extra careMDMA with SSRI antidepressants
  • Take extra careamphetamines or ADHD medicine with alcohol
  • Take extra carecannabis with alcohol
The pairs the sources rate as dangerous or as needing extra care. The most dangerous are drugs that slow the body down taken together: opioids, benzodiazepines, alcohol, GHB, and pregabalin or gabapentin. A pair that is not on this chart has not been shown to be safe. It simply is not one the sources rate.

Downers together: the most dangerous mix

The single biggest danger in this article is taking two or more drugs that slow the body down. These include opioids, benzodiazepines such as Xanax or Valium, alcohol, GHB, and the nerve-pain medicines pregabalin and gabapentin. Each one slows your breathing. Together, the effect adds up, and sometimes more than adds up.

With opioids and benzodiazepines, the risk is highest when the combination is new, in the first days of taking them together.

Pregabalin and gabapentin are easy to overlook because they’re ordinary prescription medicines, and alcohol is easy to overlook because it’s legal. All three belong on this list. If you’ve been drinking, the pill that “helps you sleep” is the one to skip.

Uppers together, and uppers with alcohol

Taking two stimulantsstimulantsDrugs that speed the body and mind up, raising heart rate and alertness. Cocaine, MDMA, amphetamines and ADHD medicines are all stimulants. together, such as cocaine with MDMA or speed, puts extra strain on the heart and makes anxiety and paranoia more likely.

Cocaine and alcohol are a very common mix, and you’ve probably seen why: cocaine makes you feel less drunk than you are, so people drink more. The two also combine in the body into a new substance, cocaethylene, which lasts longer than cocaine. You may read that it’s many times more toxic. The research is less certain than that, but the advice to avoid the combination still stands.

Cocaine with an opioid, called a speedball, is dangerous in a quieter way. The cocaine hides how sedated someone is. When it wears off first, the opioid is still working, and breathing can slow or stop.

Antidepressants, lithium and other medicines

If you take a prescribed medicine, you might be worried about how it mixes with a night out. That’s a sensible worry, and the answer depends on which medicine.

The most common antidepressants, the SSRIs, mostly weaken the effect of MDMA. The danger is taking more to chase a high that isn’t coming. An older type of antidepressant, the MAOIs, is genuinely dangerous with MDMA, and people have died. They stay in the body for up to two weeks after you stop.

Tramadol, a prescription painkiller, can cause seizures, and the risk goes up with MDMA, cocaine or antidepressants. Lithium, used for bipolar disorder, has been linked to seizures with LSD or magic mushrooms.

If you take any regular medicine, a pharmacist can tell you how it interacts with other drugs, and it’s an ordinary question to ask. Please don’t stop your own medicine to make room for a night out.

Part six of nine

If it goes wrong

What an overdose looks like, and what to do, in order

What an overdose looks like

This part is for the friend on the couch, and for you, sitting next to them, trying to work out whether to worry. Snoring or gurgling from someone who can’t be woken is one of the most important warning signs there is. It can mean their breathing is failing. People often mistake it for deep sleep.

The signs depend on the drug. With opioids and other downers, the person is very sleepy or can’t be woken, their breathing is slow or noisy, and their lips or fingertips may turn blue or gray. With stimulants and MDMA it looks the opposite: overheating, a racing heart, chest pain, confusion or a seizure. The figure below shows the signs for each.

If you’re not sure whether someone is just very high or in danger, treat it as an overdose. You won’t be overreacting! Call your local emergency number: 112 in the European Union, 999 in the UK, 911 in the US and Canada, 000 in Australia.

Is it an overdose?

The signs depend on the drug

Opioids and other downers

Heroin, fentanyl, painkillers, benzodiazepines, GHB

Signs

  • cannot be woken, or does not respond
  • slow, shallow or stopped breathing
  • snoring, gurgling or choking sounds
  • very small, pinpoint pupils
  • blue or gray lips and fingertips

WHO; CDC, US; Alcohol and Drug Foundation, Australia

First

  1. Call your local emergency number.
  2. Give naloxone if opioids could be involved, even if you are not sure.
  3. Breathing normally: recovery position. Not breathing normally: start CPR.

Stimulants

Cocaine, amphetamines, ADHD medicine

Signs

  • chest pain or tightness, also in the arm, back, neck or jaw
  • a racing or irregular heartbeat
  • severe agitation, confusion or panic
  • hot, flushed or sweaty skin
  • a seizure, or not responding

Alcohol and Drug Foundation, Australia; NIDA, US

First

  1. Call your local emergency number.
  2. Keep them calm, somewhere quiet and cool.
  3. If they stop responding but are breathing: recovery position.

Overheating on MDMA

MDMA, especially dancing in the heat

Signs

  • very hot, red skin, sometimes not sweating
  • confusion or disorientation
  • rigid muscles, or a seizure
  • a racing heart
  • vomiting

Crew, Scotland; The Loop, UK; NHS, UK

First

  1. Call your local emergency number.
  2. Cool them: a cool, wet sheet, fanning, or sponging with cold water (NHS).
  3. Stay with them until help arrives.

If you aren’t sure, treat it like an overdose. CDC, US

112 European Union999 UK911 US and Canada000 Australiaor your local emergency number

Why you stay after giving naloxone

Naloxone lasts 30 to 120 minutes Health Canada

Naloxone lasts about 30 to 90 minutes Australian Government

Heroin’s main effects last 3 to 5 hours Alcohol and Drug Foundation

Stay at least four hours CDC, US

Drugs that slow the body down cause overdoses that look like very deep sleep, with slow or noisy breathing. Stimulants and MDMA cause the opposite: overheating, a racing heart and chest pain. Naloxone reverses an opioid overdose for 30 to 120 minutes, and many opioids last longer, which is why someone who wakes up after naloxone still needs to be watched and still needs medical care.

What to do, in order

You don’t need to be a medic to help. You need to do a few things, in this order.

First, call your local emergency number. Tell them what you think was taken, even if you’re not sure. If there are any drugs left, give them to the ambulance crew. It can help them treat the person.

If opioids could be involved, give naloxone if you have it, even if you’re not sure. The next section explains it.

If they’re breathing but won’t respond, put them in the recovery position: on their side, head tilted back. The drawing below shows how. It keeps their airway open and lets any vomit drain out. Keep checking their breathing.

If they’re not breathing normally, start CPRCPRCardiopulmonary resuscitation: pressing hard and fast on the middle of the chest, with rescue breaths if you have been trained, to keep blood moving until help arrives. An emergency call handler can talk you through it.. The person on the emergency line can usually talk you through it.

Stay with them until help arrives. If they’re overheating, cool them down with a cool, wet sheet, a fan, or by sponging them with cold water.

Don’t give them coffee, and don’t put them in a cold bath to wake them up. It wastes time, and they could drown. Don’t leave them alone to sleep it off!

If you’ve been through this, it’s normal to feel shaken for days afterwards. Talk to someone about it. You did something hard.

The recovery position

For someone who is breathing but will not respond

  1. you

    1Kneel beside them and straighten their legs. Take off their glasses and anything bulky in their pockets.

  2. you

    2Put the arm nearest you out at a right angle, elbow bent, palm up. Bring the other arm across their chest and hold the back of that hand against their cheek.

  3. you

    3With your other hand, pull their far knee up so the foot is flat on the floor. Pull on that knee to roll them toward you, onto their side.

  4. you

    4Bend the top leg at a right angle. Tilt the head back and lift the chin so the airway stays open. Call for help, and keep checking their breathing.

The steps St John Ambulance teaches, which the NHS page on the recovery position now points to. On their side, with the head tilted back, the airway stays open and any vomit can drain out instead of blocking their breathing. If someone is not breathing normally, this is the wrong position: call for help and start CPR instead.

Naloxone, and where to get it

Naloxone is a medicine that reverses an opioid overdose for long enough to get help. It comes as a nasal spray or an injection, and it takes very little training to use.

It’s safe to give when you’re not sure. If the person hasn’t taken opioids, it does nothing. It won’t reverse other drugs, but give it anyway if opioids could be part of the mix. With the newest, strongest opioids, more than one dose may be needed. If they’re still not breathing normally 2 to 3 minutes after a dose, give another one if you have it.

It wears off, often within half an hour to two hours, and many opioids last longer. So someone can stop breathing again after they seem fine. That’s why you stay with them, and why they still need medical care after they wake up, even if they tell you they’re okay.

How you get naloxone depends on where you live. In the US it’s sold over the counter. In Canada most pharmacies give it without a prescription, and some provinces give it free. In Australia it’s free without a prescription. In the UK, drug services can hand it out. In Europe, availability differs by country, and many run take-home programs. You can’t give it to yourself, so if you carry it, tell your friends where it is.

Will I get in trouble for calling?

If this is what’s making you hesitate, plenty of people feel the same, and it’s a fair question. In many places the law protects people who call for help in an overdose. And even where it doesn’t, calling is still the right thing to do. A life matters more than the trouble!

In the US, every state has some kind of Good Samaritan law, although what it covers varies a lot. In Canada, the law protects the person who calls from charges of having drugs, whether they stay or leave. In the UK there’s no specific law, but ambulance crews usually don’t involve the police. Elsewhere, the rules vary, so find out what they are where you live before you need them.

Never using alone

Almost all overdose advice depends on one thing: someone else being there, who can notice, call for help, give naloxone and put you on your side.

Sometimes that isn’t possible, and there’s no shame in that. Some countries have phone lines for exactly this moment. In the US, Never Use Alone stays on the line while you use and sends help if you stop answering. Canada’s National Overdose Response Service does the same.

Part seven of nine

When the pills came from a prescription

Someone else’s medicine, benzodiazepines, painkillers, and a break in use

In plain words

This part is about taking medicine meant for someone else, or taking your own differently from how you were told. If your own treatment for ADHD, anxiety or pain works for you, nothing here is a reason to stop, and any questions about it belong with your doctor.

A real medicine contains what the label says. But how safe it is depends on who takes it, how much and with what, and that doesn’t travel with the pill.

A friend’s ADHD pills can look like the answer in exam week. In healthy people, though, the boost is small at best. In one US study, students who used them didn’t get better grades. The pills raise your heart rate and blood pressure, and they make it hard to sleep. The person they were prescribed for was checked for heart problems first, and you weren’t. In the US, fakes sold online have been found to contain meth or fentanyl. Mixing them with alcohol makes them riskier, and anyone who takes them anyway is safer if someone else knows what they’ve taken.

Benzodiazepines calm anxiety and help with sleep, and they’re useful medicines in the short term. Dependence can start within days to weeks, even when you take them exactly as prescribed. That’s how these medicines work, and it’s no personal failing. Stopping suddenly after regular use can cause seizures, which can be life-threatening. If you’ve been taking them regularly, you should come off slowly, with a doctor’s help.

Benzos bought outside a pharmacy vary in strength, and some fake ones now contain nitazenes. With opioids or alcohol, benzos are part of the most dangerous mix in part five.

Leftover painkillers like codeine, tramadol and oxycodone can seem harmless because a doctor prescribed them. They carry the same overdose risk as other opioids, especially for someone who has never taken them before. Some painkillers mix codeine with paracetamol, which Americans call acetaminophen, or with ibuprofen or aspirin. Taking extra to feel more of the codeine means taking extra of the other painkiller too, and that can poison you.

If you’ve been on an opioid painkiller for weeks, talk to your prescriber before stopping. Leftover medicine is safest out of the house, and in the US, take-back programs collect it.

Tolerance drops fast when someone stops, often within days. That makes the weeks after a break the most dangerous time, and it often comes just when someone has been working hard to change. The risk of dying is much higher in the first weeks after leaving prison, after detox, or after stopping treatment with methadone or buprenorphine. With opioids especially, the amount you used to take can now be enough to kill you.

If you go back after a break, don’t use alone, and keep naloxone nearby if opioids are involved. Going back is no reason for shame, but it does need care.

This is not about your own prescription

This part is about taking medicine that was meant for someone else, or taking your own in a different way from how you were told. It’s not about taking your own medicine the way your doctor intended. If your treatment for ADHD, anxiety or pain works for you, nothing here is a reason to stop, and any questions about it belong with your doctor.

Prescription pills feel safer than street drugs. In one way they are, because a real medicine contains what the label says. But that safety depends on who takes it, how much, and with what. It doesn’t travel with the pill.

Someone else’s ADHD medicine

Exam week, too much to do, and a friend offers you one of their ADHD pills. It’s easy to see why you’d say yes. The evidence is disappointing, though. In healthy people the boost is small at best, and in one US study, students who used them didn’t get better grades.

The costs are more reliable. These pills raise your heart rate and blood pressure, and they make it hard to sleep. The person they were prescribed for was checked for heart problems first, and you weren’t. In the US, fakes sold online have been found to contain meth or fentanyl.

If you take them anyway, start with a small amount, don’t mix them with alcohol, and tell someone what you’ve taken. And if you’re this stretched, the pressure deserves attention as much as the pill does. Our article on sleep explains why an all-nighter is such a questionable strategy in the first place.

Benzodiazepines

Benzodiazepines, such as Valium and Xanax, calm anxiety and help with sleep. If you’ve ever been prescribed one during a hard time, you’ll know how much relief they can bring. They’re useful medicines in the short term, but they carry two risks many people don’t know about.

The first is dependence, which can start within days to weeks, even when you take them exactly as prescribed. That isn’t a personal failing. It’s how these medicines work. The second follows from it: stopping suddenly after regular use can cause seizures, which can be life-threatening. If you’ve been taking them regularly, you should come off slowly, with a doctor’s help.

Benzos bought outside a pharmacy are a different problem. Their strength is unpredictable, and some fake ones now contain nitazenes. FRANK’s advice, if you take a street benzo anyway, is to “try a small amount (half a pill) of it first and wait at least an hour”. With opioids or alcohol, they’re part of the most dangerous mix in part five.

Opioid painkillers

Leftover painkillers from an operation, or a few from a relative’s cabinet, can seem harmless because they came from a doctor. Codeine, tramadol and oxycodone relieve pain and make people relaxed and sleepy. They carry the same overdose risk as other opioids, especially if you’ve never taken them before.

Some painkillers mix codeine with paracetamol, which Americans call acetaminophen, or with ibuprofen or aspirin. Taking extra to feel more of the codeine means taking extra of the other painkiller too, which can poison you. The ordinary painkiller becomes the dangerous part.

If you’ve been on an opioid painkiller for weeks, talk to your prescriber before stopping. And leftover medicine is safest out of the house: in the US, take-back programs collect it.

After a break, your usual amount can be too much

Tolerance is how your body gets used to a drug, so the same amount does less. It builds up with regular use, and it drops surprisingly fast when you stop, often within days.

That makes the weeks after a break the most dangerous time of all, and it’s cruel timing, because it’s often when someone has been working hard to change. The risk of dying is much higher in the first weeks after leaving prison, after detox, or after stopping treatment with methadone or buprenorphine. With opioids especially, the amount you used to take can now be enough to kill you. Going back after a break is no reason for shame, but it does need care.

IF YOU GO BACK AFTER A BREAK

  • Start with much less than before.
  • Don’t use alone.
  • Keep naloxone nearby if opioids are involved.

Part eight of nine

Your mind, and when it becomes a problem

Comedowns, psychosis, using to cope, and what helps

In plain words

After MDMA, cocaine or ketamine, it’s common to feel low, anxious or on edge for a day or a few days. Knowing that the low is the drug wearing off, and not the truth about your life, can make it easier to wait out. Be gentle with yourself while it passes. Pay attention if it lasts longer than a comedown should, keeps coming back, or you find yourself using again to get out of it.

Low mood after using can make everything feel worse than it is. If you’re having thoughts of harming yourself, please tell someone rather than carrying them alone. Our article on suicidal thoughts says where to find someone to talk to, wherever you are.

Psychosis means losing touch with what’s real, like hearing or seeing things that aren’t there, or believing frightening things other people don’t. Several drugs can trigger it. For most people it passes as the drug wears off, and for a smaller number it doesn’t.

Cannabis has the clearest link. People who use strong cannabis every day are several times more likely to develop psychosis than people who never use it. The risk is highest with heavy use of strong cannabis started young, and in young men. Research can’t fully prove that cannabis causes it, but the studies keep pointing the same way. LSD and mushrooms can trigger psychosis in people who are already vulnerable to it.

So be most careful if you’re young, or if psychosis, schizophrenia or bipolar disorder runs in your family. If you hear or see things that don’t go away, or feel paranoid for days after using, see a doctor promptly. A first episode is worth following up even if it fades, and getting help early is nothing to be ashamed of.

Sometimes using starts as fun and turns into the thing that gets you through, a way to take the edge off stress or to feel nothing for a night. About one in five people with depression or anxiety use alcohol or drugs to cope. It works in the moment. Over time, though, drugs can make anxiety and low mood worse, and that often eases once the drug use stops.

You don’t need to stop using before you get help for how you feel. International treatment guidelines say help for anxiety or depression should never wait for that. You can bring the using and the reasons into the same conversation.

Using often isn’t the same as having a problem. The World Health Organization says even daily use doesn’t automatically mean dependence. A problem shows up as a change in how you relate to the drug.

You use more than you meant to, or can’t cut down when you try. You give up things you care about, or keep going even though it’s hurting your health, your work or the people you love. You need more for the same effect, and you feel unwell when you stop. The private check below asks eleven plain questions. Nothing you tick is saved or sent anywhere, and it isn’t a diagnosis.

Treatment works, and help doesn’t have to wait for a crisis. For opioids, medicines such as methadone and buprenorphine have the strongest evidence, and they roughly halve the risk of dying. For cocaine and other uppers there’s no approved medicine yet. What works best is a program that rewards people with vouchers or small prizes for negative drug tests. Talking therapies help too, and groups such as Narcotics Anonymous offer support from people who have been there.

Recovery is common! In a large US survey, about one adult in eleven said they used to have a problem with alcohol or drugs and no longer did. Nearly half of them got there without treatment or a support group.

A doctor is usually a good place to start. In many countries what you tell a doctor stays confidential, with a few exceptions such as serious risk to you or someone else. The rules vary, and it’s fine to ask about confidentiality before you say anything. If you’re worried about your use, or you’ve started using to cope, that’s reason enough to talk to someone.

Comedowns, anxiety and low mood

The day after can be hard. After MDMA, cocaine or ketamine, it’s common to feel low, anxious or on edge for a day or a few days. Knowing that a low is the drug wearing off, and not the truth about your life, can make it easier to wait out. Be gentle with yourself while it passes.

Pay attention if the low lasts longer than a comedown should, keeps coming back, or if you find yourself using again to get out of it.

Low mood after using can make everything feel worse than it is. If you’re having thoughts of harming yourself, please tell someone rather than carrying them alone. Our article on suicidal thoughts says where to find someone to talk to, wherever you are.

Psychosis, and who should be most careful

Psychosis means losing touch with what is real: hearing or seeing things that aren’t there, or believing frightening things other people don’t. It’s terrifying to go through, and just as frightening to watch in a friend. Several drugs can trigger it. For most people it passes as the drug wears off. For a smaller number it doesn’t.

Cannabis has the clearest evidence. People who use strong cannabis every day are several times more likely to develop psychosis than people who never use it. The risk is highest with heavy use of strong cannabis, started young, and in young men. The research can’t fully prove cause and effect, but it keeps pointing the same way.

LSD and mushrooms can trigger psychosis in people who are already vulnerable to it. That’s why research trials leave out anyone with a personal or family history of psychosis.

So be most careful if psychosis, schizophrenia or bipolar disorder runs in your family, and if you’re young. If you hear or see things that don’t go away, or feel paranoid for days after using, see a doctor promptly. A first episode is worth following up, even if it fades, and getting help early is nothing to be ashamed of.

Using to cope

Maybe it started as fun, and somewhere along the way it became the thing that gets you through. You might use it to take the edge off stress, to stop thinking for a while, or just to feel nothing for a night. If that’s you, there’s nothing strange about it. About one in five people with depression or anxiety use alcohol or drugs to cope.

It works in the moment, and that’s the trouble. Over time, drugs can make anxiety and low mood worse, and that often eases once the drug use stops. The relief becomes the reason to use, and the reason keeps growing. Our article on dopamine explains that shift, from using for pleasure to using for relief, and why knowing it’s bad for you doesn’t stop the wanting.

If this sounds familiar, you do not need to stop before getting help for how you feel. International treatment guidelines say help for anxiety or depression should never wait until someone has stopped using. You can bring all of it, the using and the reasons, into the same conversation.

When use becomes a problem

Using a drug often is not the same as having a problem with it. The World Health Organization says so plainly: frequent or even daily use does not automatically mean dependence.

What marks a problem is a change in your relationship with the drug. You use more, or for longer, than you meant to. You try to cut down and don’t manage it. You give up things you used to care about, or carry on even though it’s hurting your health, your work or the people you love. You need more to get the same effect, and you feel unwell when you stop.

If you’re asking yourself the question at all, that’s worth listening to. The check below turns those signs into eleven plain questions, based on the ones doctors use. Nothing you tick is saved or sent anywhere. It’s not a diagnosis. It’s there to help you see the pattern and find the right kind of help.

A private check

In the past year, have you…

0 of 11

Tick any that apply. Nothing you tick is stored or sent anywhere.

The eleven signs doctors use to recognize a drug problem, reworded so they fit any drug. Two or more in a year is where the criteria begin. Two or three count as mild, four or five as moderate, six or more as severe. This is not a diagnosis. Frequent use on its own is not dependence, and only a conversation with a professional can tell you what your answers mean.

What helps

Reaching out about drugs can feel exposing, especially if you’ve been keeping it to yourself for a while. The first conversation is often the hardest part. Treatment works, and help doesn’t have to wait for a crisis. Most drug problems can be treated well when people can get the right kind of help.

For opioids, medicines such as methadone and buprenorphine have the strongest evidence of any treatment, and they roughly halve the risk of dying. For stimulants such as cocaine, there’s no approved medicine yet, and what works best is contingency management, which rewards people with vouchers or small prizes for negative drug tests. Talking therapies help too. Cognitive behavioral therapy works better than no treatment, and motivational interviewing, a way of talking through what you want to change, can help a little, as a place to start. Groups such as Narcotics Anonymous offer support from people who have been there.

Recovery is common! In a large US survey, about one adult in eleven said they used to have a problem with alcohol or drugs and no longer did. Nearly half of them got there without treatment or a support group.

A doctor is usually a good place to start. In many countries what you tell a doctor stays confidential, with a few exceptions such as serious risk to you or someone else. The rules vary, and it’s fine to ask about confidentiality before you say anything.

Where drug use is a crime, or a record could reach your family, your job or your visa, telling a doctor can feel like a risk, and sometimes it is. Harm reduction services, where there’s one near you, usually don’t need your name or a promise to stop, and in many places a pharmacist will answer questions about medicines and mixes in confidence.

If you’d rather talk to someone else first, you can find the crisis lines for your country on our helplines page. In the UK, FRANK is on 0300 123 6600. In the US, the SAMHSA National Helpline is free, confidential and open day and night on 1-800-662-4357. In Australia, the National Alcohol and Other Drug Hotline is on 1800 250 015. Canada has no single national line, and Health Canada lists the services available.

Part nine of nine

Everything else you were too afraid to ask

Short, plain answers to the questions people rarely say out loud

These are the questions people type into a search bar late at night, or ask a friend instead of a doctor. None of them is a silly question, and each has a short answer.

What about laughing gas?

Nitrous oxide, sold in small metal canisters and breathed in from balloons, works in seconds and wears off in a minute or two. That makes it seem harmless, but it isn’t. Breathing it can starve your body of oxygen, and people have died this way. The canisters are also cold enough to burn your skin.

Heavy, regular use causes a different problem. It stops your body using vitamin B12 properly, which can damage the nerves, even when a blood test shows normal B12. If you’ve noticed tingling, numbness or trouble walking after using it regularly, see a doctor and tell them about the nitrous. There is treatment, but recovery is often only partial, so don’t wait.

If you use it, sit down rather than standing or dancing, don’t use alone, take breaks in fresh air, never put anything over your head, and don’t mix it with alcohol or other drugs.

Laughing gas works in seconds and wears off in a minute or two, so it can seem harmless. It isn’t. Breathing it can starve your body of oxygen, and people have died this way. The canisters get cold enough to burn your skin.

Heavy, regular use stops your body using vitamin B12 properly, which can damage your nerves, even when a blood test shows normal B12. If you’ve noticed tingling, numbness or trouble walking after using it regularly, see a doctor and tell them about the nitrous. There is treatment, but recovery is often only partial, so don’t wait.

Never use it alone, and never put anything over your head. Standing or dancing on it, going without breaks in fresh air, and mixing it with alcohol or other drugs all make it more dangerous.

What about GHB?

GHB and GBL are drugs that slow the body down. They’re sometimes called geebs or liquid ecstasy, although they have nothing to do with ecstasy. The gap between the amount that gives people the effect they want and the amount that causes a serious overdose is very small.

With alcohol or other downers, the risk rises sharply, and people can pass out quickly. FRANK advises waiting “at least two hours before taking another dose”. GHB has also been linked to sexual assaults, so it’s worth keeping an eye on your drink. If something happened to you that you didn’t agree to, it isn’t your fault, and you deserve support.

Stopping GHB after regular use can cause severe withdrawal. That needs a doctor, not willpower.

GHB and GBL slow the body down. People call them geebs or liquid ecstasy, but they have nothing to do with ecstasy. The amount that gives people the effect they want is very close to the amount that causes a serious overdose. With alcohol or other downers, the risk rises sharply, and people can pass out quickly. FRANK warns that taking more within two hours is too soon. GHB has also been linked to sexual assaults, so keep an eye on your drink. If something happened to you that you didn’t agree to, it isn’t your fault, and you deserve support. Stopping GHB after regular use can cause severe withdrawal. That needs a doctor, not willpower.

Can you overdose on cannabis?

Nobody has been shown to die from cannabis alone. But cannabis emergencies are real: panic, a racing heart, vomiting, edibles taken in far bigger amounts than intended, and children who eat edibles by accident. If you’ve had a panic on cannabis, it usually passes as it wears off. Sit somewhere calm, breathe slowly, and have someone stay with you.

There’s also a hidden risk. Synthetic cannabinoids are lab-made chemicals sometimes sold as cannabis or sprayed onto it. They’re much stronger and less predictable, and they can kill.

Nobody has been shown to die from cannabis alone. But cannabis emergencies are real, such as panic, a racing heart, vomiting, eating far more edibles than intended, and children eating edibles by accident. A panic on cannabis usually passes as it wears off. Sit somewhere calm, breathe slowly, and have someone stay with you. Synthetic cannabinoids are a hidden risk. They’re lab-made chemicals sometimes sold as cannabis or sprayed onto it, much stronger and less predictable, and they can kill.

Is cannabis a gateway drug?

People who use other drugs have usually tried cannabis first. But that doesn’t mean cannabis caused it. Large international surveys suggest the same things that lead someone to try cannabis can also lead them to try other drugs. Most people who use cannabis never go on to use other drugs.

People who use other drugs have usually tried cannabis first. That doesn’t mean cannabis caused it. Large international surveys suggest the same things that lead someone to try cannabis can also lead them to try other drugs. Most people who use cannabis never go on to use other drugs.

Magic mushrooms are natural. Doesn’t that make them safe?

Natural says nothing about safety! The biggest danger with magic mushrooms is picking a poisonous one by mistake, because some deadly species look very like the ones people pick. If there’s any doubt about what a mushroom is, don’t take it. Strength also varies a lot, even between mushrooms that look the same.

Natural says nothing about safety! The biggest danger is picking a poisonous mushroom by mistake, because some deadly kinds look a lot like the ones people pick. If there’s any doubt about what a mushroom is, don’t take it. Strength also varies a lot, even between mushrooms that look the same.

Are psychedelics addictive?

LSD and magic mushrooms carry a low risk of addiction. That doesn’t make them risk-free. Bad trips, accidents, psychosis in people who are vulnerable, and the lithium interaction in part five are all real.

LSD and magic mushrooms carry a low risk of addiction. That doesn’t make them risk-free. Bad trips, accidents, psychosis in people who are vulnerable, and seizures linked to taking them with lithium are all real.

What about psychedelic and ketamine therapy?

You may have read about trials of psilocybin, the active ingredient in magic mushrooms, for depression, and about ketamine clinics. If you’re struggling with depression, it’s understandable to find that hopeful. A nasal spray made from ketamine is approved for severe depression that has not responded to other treatment in the US, the European Union, Australia and several other countries.

What happens in those trials is very different from taking the same drug at home or at a party. Volunteers are screened, the dose is known, and trained staff stay with them the whole time. A trial result is not evidence that using on your own is safe. If that treatment interests you, ask a doctor about it rather than trying to recreate it.

You may have read about trials of psilocybin, the active part of magic mushrooms, for depression, and about ketamine clinics. If you’re struggling with depression, it makes sense to find that hopeful. In the US, the European Union, Australia and several other countries, a nasal spray made from ketamine is approved for severe depression that other treatments haven’t helped. Trials are very different from using at home or at a party. Volunteers are screened, the dose is known, and trained staff stay with them the whole time. A trial result doesn’t show that using on your own is safe. If that treatment interests you, ask a doctor about it rather than trying to recreate it.

Does coffee or a cold shower sober you up?

No, they don’t. Coffee, cold showers and walking it off don’t undo alcohol or drugs, and they can make things worse. A cold bath also brings a risk of drowning. Someone who can’t be woken needs an ambulance, not coffee.

No. Coffee, cold showers and walking it off don’t undo alcohol or drugs, and they can make things worse. A cold bath also brings a risk of drowning. Someone who can’t be woken needs an ambulance, not coffee.

Does cocaine sober you up when you have been drinking?

It can make you feel less drunk, which isn’t the same thing. You are just as drunk, and now you’re also on cocaine. It also tends to make people drink more. Part five explains why the two are best kept apart.

No. It can make you feel less drunk, but you’re just as drunk, and now you’re on cocaine too. It also tends to make people drink more. Part five explains why the two are best kept apart.

Doesn’t naloxone just let people use more?

This has been studied, and the evidence does not support it. Handing out naloxone hasn’t been found to increase drug use or overdoses. It does one thing: it gives someone who has stopped breathing a chance to be alive when the ambulance arrives.

This has been studied, and the evidence doesn’t support it. Handing out naloxone hasn’t been found to increase drug use or overdoses. It gives someone who has stopped breathing a chance to be alive when the ambulance arrives.

Should I tell a doctor or paramedic what I have taken?

Yes, you should. It can feel scary to say it out loud, but what you took changes what they need to do, and in an emergency it can save your life. They ask because they need to know, not to judge you, and in many countries they keep it confidential. If you’re unsure what happens to the information where you live, you can ask before you answer.

Yes. It can feel scary to say it out loud, but what you took changes what they need to do, and in an emergency it can save your life. They ask because they need to know, not to judge you, and in many countries they keep it confidential. If you’re not sure what happens to that information where you live, you can ask before you answer.

WHAT THE RESEARCH SUPPORTS

The strongest evidence in this article is on four points. Naloxone reverses opioid overdoses and has not been found to increase drug use. Medicines such as methadone and buprenorphine roughly halve the risk of dying for people dependent on opioids. Drugs that slow the body down are most dangerous together, and with opioids and benzodiazepines the risk is highest when the combination is new. And tolerance drops quickly after a break, which makes the weeks after prison, detox or treatment especially dangerous.

WORTH BEING CLEAR ABOUT

Much of the practical advice here comes from national drug advice services rather than from trials, because nobody runs a trial on how long to wait between doses. Where those services disagree, the figures show both. Tools such as drug checking and test strips are widely recommended but have not yet been shown to prevent deaths.

Drugs change quickly, and what turns up in pills and powders one year can be different the next. Laws and services differ from country to country and change too. Treat the details here as a starting point, and check with a local service where you can.

None of this makes drugs safe, and nothing could. What it can do is move the odds, for you and for the people you’re with. Most of the harm described here comes from a handful of things: not knowing how strong something is, mixing, using alone, and not knowing what to do when a friend won’t wake up. Each of those can be changed tonight, and now you know how.

REFERENCES

  1. Abrahao, K. P., Salinas, A. G., & Lovinger, D. M. (2017). Alcohol and the brain: Neuronal molecular targets, synapses, and circuits. Neuron, 96(6), 1223-1238.
  2. Alcohol and Drug Foundation (Australia). (n.d.). Drug facts: cannabis, cocaine, dexamphetamine, GHB, heroin, ketamine, LSD, MDMA, nitrous oxide and psilocybin; Polydrug use.
  3. Arria, A. M., Caldeira, K. M., Vincent, K. B., O’Grady, K. E., Cimini, M. D., Geisner, I. M., Fossos-Wong, N., Kilmer, J. R., & Larimer, M. E. (2017). Do college students improve their grades by using prescription stimulants nonmedically? Addictive Behaviors, 65, 245-249.
  4. Australian Government Department of Health, Disability and Ageing. (2025). National Alcohol and Other Drug Hotline.
  5. Australian Government Department of Health, Disability and Ageing. (2026). About the Take Home Naloxone program.
  6. Bachmutsky, I., Wei, X. P., Kish, E., & Yackle, K. (2020). Opioids depress breathing through two small brainstem sites. eLife, 9, Article e52694.
  7. Bentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021). Comparison of treatments for cocaine use disorder among adults. JAMA Network Open, 4(5), Article e218049.
  8. Berger, M., Gray, J. A., & Roth, B. L. (2009). The expanded biology of serotonin. Annual Review of Medicine, 60(1), 355-366.
  9. Brett, J., & Murnion, B. (2015). Management of benzodiazepine misuse and dependence. Australian Prescriber, 38(5), 152-155.
  10. Britch, S. C., & Walsh, S. L. (2022). Treatment of opioid overdose: Current approaches and recent advances. Psychopharmacology, 239(7), 2063-2081.
  11. Busardò, F. P., & Jones, A. W. (2015). GHB pharmacology and toxicology: Acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Current Neuropharmacology, 13(1), 47-70.
  12. Centers for Disease Control and Prevention (US). (2024). Fentanyl facts.
  13. Centers for Disease Control and Prevention (US). (2024). What to do if you think someone is overdosing.
  14. Centers for Disease Control and Prevention (US). (2025). Lifesaving naloxone.
  15. Centers for Disease Control and Prevention (US). (2026). Medetomidine in the U.S. illegal fentanyl supply increasing risk for overdose and severe withdrawal syndrome [Health advisory].
  16. Crew 2000 (Scotland). (n.d.). Drug information: cocaine, ketamine, LSD, magic mushrooms and MDMA.
  17. Curran, H. V., & Travill, R. A. (1997). Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): Week-end “high” followed by mid-week low. Addiction, 92(7), 821-831.
  18. De Crescenzo, F., Ciabattini, M., D’Alò, G. L., De Giorgi, R., Del Giovane, C., Cassar, C., Janiri, L., Clark, N., Ostacher, M. J., & Cipriani, A. (2018). Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis. PLOS Medicine, 15(12), Article e1002715.
  19. Degenhardt, L., Dierker, L., Chiu, W. T., Medina-Mora, M. E., Neumark, Y., Sampson, N., Alonso, J., Angermeyer, M., Anthony, J. C., Bruffaerts, R., de Girolamo, G., de Graaf, R., Gureje, O., Karam, A. N., Kostyuchenko, S., Lee, S., Lépine, J.-P., Levinson, D., Nakamura, Y., . . . Kessler, R. C. (2010). Evaluating the drug use “gateway” theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug and Alcohol Dependence, 108(1-2), 84-97.
  20. De Vrieze, L. M., Stove, C. P., & Vandeputte, M. M. (2024). Nitazene test strips: A laboratory evaluation. Harm Reduction Journal, 21(1), Article 159.
  21. Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., La Barbera, D., Tarricone, I., Berardi, D., Szöke, A., Arango, C., Tortelli, A., Velthorst, E., Bernardo, M., Del-Ben, C. M., . . . van der Ven, E. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. The Lancet Psychiatry, 6(5), 427-436.
  22. Drug Enforcement Administration (US). (n.d.). One pill can kill.
  23. European Medicines Agency. (2025). Spravato [European public assessment report].
  24. European Union Drugs Agency. (2026). European drug report 2026: Trends and developments.
  25. Faraone, S. V. (2018). The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience & Biobehavioral Reviews, 87, 255-270.
  26. Farré, M., Abanades, S., Roset, P. N., Peiró, A. M., Torrens, M., O’Mathúna, B., Segura, M., & de la Torre, R. (2007). Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: Pharmacological effects and pharmacokinetics. The Journal of Pharmacology and Experimental Therapeutics, 323(3), 954-962.
  27. Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health, 107(8), e1-e12.
  28. FRANK (UK). (n.d.). Drugs A to Z: benzodiazepines, cannabis, cocaine, ecstasy, GHB, heroin, ketamine, LSD, magic mushrooms, nitrous oxide, opioid painkillers and synthetic opioids.
  29. FRANK (UK). (n.d.). What to do in an emergency.
  30. Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M., & Lynskey, M. T. (2021). Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: Systematic review and meta‐analysis. Addiction, 116(5), 1000-1010.
  31. Garcia, M. R., Gomes, N. G. M., & Dias‐da‐Silva, D. (2026). Rare but relevant: MDMA and hyponatraemia. Addiction, 121(3), 713-718.
  32. Gomes, T., Juurlink, D. N., Antoniou, T., Mamdani, M. M., Paterson, J. M., & van den Brink, W. (2017). Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLOS Medicine, 14(10), Article e1002396.
  33. Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacological Reviews, 55(3), 463-508.
  34. Halifax, J. C., Lim, L., Ciccarone, D., & Lynch, K. L. (2024). Testing the test strips: Laboratory performance of fentanyl test strips. Harm Reduction Journal, 21(1), Article 14.
  35. Hassamal, S., Miotto, K., Dale, W., & Danovitch, I. (2018). Tramadol: Understanding the risk of serotonin syndrome and seizures. The American Journal of Medicine, 131(11), 1382.e1-1382.e6.
  36. Health Canada. (2026). About the Good Samaritan Drug Overdose Act.
  37. Health Canada. (2026). Get help with substance use.
  38. Health Canada. (2026). Naloxone.
  39. Hernandez, I., He, M., Brooks, M. M., & Zhang, Y. (2018). Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries. JAMA Network Open, 1(2), Article e180919.
  40. Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry, 17(6), 642-649.
  41. Hjorthøj, C., Compton, W., Starzer, M., Nordholm, D., Einstein, E., Erlangsen, A., Nordentoft, M., Volkow, N. D., & Han, B. (2023). Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological Medicine, 53(15), 7322-7328.
  42. Hysek, C. M., Schmid, Y., Rickli, A., Simmler, L. D., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British Journal of Pharmacology, 166(8), 2277-2288.
  43. Ilieva, I. P., Hook, C. J., & Farah, M. J. (2015). Prescription stimulants’ effects on healthy inhibitory control, working memory, and episodic memory: A meta-analysis. Journal of Cognitive Neuroscience, 27(6), 1069-1089.
  44. Jauhar, S., Cowen, P. J., & Browning, M. (2023). Fifty years on: Serotonin and depression. Journal of Psychopharmacology, 37(3), 237-241.
  45. Jesse, S., Bråthen, G., Ferrara, M., Keindl, M., Ben-Menachem, E., Tanasescu, R., Brodtkorb, E., Hillbom, M., Leone, M. A., & Ludolph, A. C. (2017). Alcohol withdrawal syndrome: Mechanisms, manifestations, and management. Acta Neurologica Scandinavica, 135(1), 4-16.
  46. Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22(6), 603-620.
  47. Kelly, J. F., Bergman, B. G., Hoeppner, B. B., Vilsaint, C., & White, W. L. (2017). Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug and Alcohol Dependence, 181, 162-169.
  48. Kutscher, E., Barber Grossi, M., LaPolla, F., & Lee, J. D. (2024). Fentanyl test strips for harm reduction: A scoping review. Journal of Addiction Medicine, 18(4), 373-380.
  49. Legislative Analysis and Public Policy Association (US). (2025). Good Samaritan fatal overdose prevention and drug-induced homicide: Summary of state laws.
  50. Lockwood, T.-L. E., Vervoordt, A., & Lieberman, M. (2021). High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduction Journal, 18(1), Article 30.
  51. The Loop (UK). (2026). 2026 MDMA pill update.
  52. Lu, H.-C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological Psychiatry, 79(7), 516-525.
  53. Maghsoudi, N., Tanguay, J., Scarfone, K., Rammohan, I., Ziegler, C., Werb, D., & Scheim, A. I. (2022). Drug checking services for people who use drugs: A systematic review. Addiction, 117(3), 532-544.
  54. Magill, M., Ray, L., Kiluk, B., Hoadley, A., Bernstein, M., Tonigan, J. S., & Carroll, K. (2019). A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of Consulting and Clinical Psychology, 87(12), 1093-1105.
  55. Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262-1269.
  56. Marsden, P., Sharma, A. A., & Rotella, J. (2022). Review article: Clinical manifestations and outcomes of chronic nitrous oxide misuse: A systematic review. Emergency Medicine Australasia, 34(4), 492-503.
  57. Medicines and Healthcare products Regulatory Agency (UK). (2021). Pregabalin (Lyrica): Reports of severe respiratory depression [Drug safety update].
  58. Merrall, E. L. C., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J., Hutchinson, S. J., & Bird, S. M. (2010). Meta‐analysis of drug‐related deaths soon after release from prison. Addiction, 105(9), 1545-1554.
  59. Miró, Ò., Galicia, M., Dargan, P., Dines, A. M., Giraudon, I., Heyerdahl, F., Hovda, K. E., Yates, C., Wood, D. M., Liakoni, E., Liechti, M., Jürgens, G., Pedersen, C. B., O’Connor, N., Markey, G., Moughty, A., Lee, C., O’Donohoe, P., Sein Anand, J., . . . Kabata, P. M. (2017). Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicology Letters, 277, 84-91.
  60. Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28(8), 3243-3256.
  61. Myran, D. T., Tanuseputro, P., Auger, N., Konikoff, L., Talarico, R., & Finkelstein, Y. (2023). Pediatric hospitalizations for unintentional cannabis poisonings and all-cause poisonings associated with edible cannabis product legalization and sales in Canada. JAMA Health Forum, 4(1), Article e225041.
  62. National Institute on Alcohol Abuse and Alcoholism (US). (n.d.). Alcohol use disorder: A comparison between DSM-IV and DSM-5.
  63. National Institute on Alcohol Abuse and Alcoholism (US). (n.d.). Understanding the dangers of alcohol overdose.
  64. National Institute on Drug Abuse (US). (n.d.). Drugs and the brain.
  65. National Institute on Drug Abuse (US). (n.d.). Research topics: cannabis, cocaine, psilocybin, and psychedelic and dissociative drugs.
  66. Nayak, S. M., Gukasyan, N., Barrett, F. S., Erowid, E., Erowid, F., & Griffiths, R. R. (2021). Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: An analysis of online psychedelic experience reports. Pharmacopsychiatry, 54(05), 240-245.
  67. Never Use Alone (US). (n.d.). Never Use Alone.
  68. NHS (UK). (n.d.). Heat exhaustion and heatstroke.
  69. NHS (UK). (n.d.). Methylphenidate for adults.
  70. Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264-355.
  71. Pattinson, K. T. S., Governo, R. J., MacIntosh, B. J., Russell, E. C., Corfield, D. R., Tracey, I., & Wise, R. G. (2009). Opioids depress cortical centers responsible for the volitional control of respiration. The Journal of Neuroscience, 29(25), 8177-8186.
  72. Pennings, E. J. M., Leccese, A. P., & Wolff, F. A. d. (2002). Effects of concurrent use of alcohol and cocaine. Addiction, 97(7), 773-783.
  73. Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199-215.
  74. Pincock, S. (2003). Science forced to retract article on “ecstasy”. BMJ, 327(7415), 579.
  75. Queensland Brain Institute (Australia). (n.d.). Action potentials and synapses.
  76. Rogers, G., Elston, J., Garside, R., Roome, C., Taylor, R., Younger, P., Zawada, A., & Somerville, M. (2009). The harmful health effects of recreational ecstasy: A systematic review of observational evidence. Health Technology Assessment, 13(6), 1-354.
  77. Roxburgh, A., Sam, B., Kriikku, P., Mounteney, J., Castanera, A., Dias, M., & Giraudon, I. (2021). Trends in MDMA‐related mortality across four countries. Addiction, 116(11), 3094-3103.
  78. Santo, T., Clark, B., Hickman, M., Grebely, J., Campbell, G., Sordo, L., Chen, A., Tran, L. T., Bharat, C., Padmanathan, P., Cousins, G., Dupouy, J., Kelty, E., Muga, R., Nosyk, B., Min, J., Pavarin, R., Farrell, M., & Degenhardt, L. (2021). Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis. JAMA Psychiatry, 78(9), 979-993.
  79. Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022). Drug-drug interactions between psychiatric medications and MDMA or psilocybin: A systematic review. Psychopharmacology, 239(6), 1945-1976.
  80. Schwenker, R., Dietrich, C. E., Hirpa, S., Nothacker, M., Smedslund, G., Frese, T., & Unverzagt, S. (2023). Motivational interviewing for substance use reduction. Cochrane Database of Systematic Reviews, 2023(12), Article CD008063.
  81. Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019). Serotonin syndrome: Pathophysiology, clinical features, management, and potential future directions. International Journal of Tryptophan Research, 12, Article 1178646919873925.
  82. Siebers, M., Biedermann, S. V., Bindila, L., Lutz, B., & Fuss, J. (2021). Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology, 126, Article 105173.
  83. Sigel, E., & Ernst, M. (2018). The benzodiazepine binding sites of GABAA receptors. Trends in Pharmacological Sciences, 39(7), 659-671.
  84. Simmler, L. D., Hysek, C. M., & Liechti, M. E. (2011). Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. The Journal of Clinical Endocrinology & Metabolism, 96(9), 2844-2850.
  85. St John Ambulance (UK). (n.d.). How to put someone in the recovery position.
  86. Substance Abuse and Mental Health Services Administration (US). (n.d.). SAMHSA’s National Helpline.
  87. Sulzer, D. (2011). How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron, 69(4), 628-649.
  88. Taylor, C. P., Angelotti, T., & Fauman, E. (2007). Pharmacology and mechanism of action of pregabalin: The calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research, 73(2), 137-150.
  89. Tse, W. C., Djordjevic, F., Borja, V., Picco, L., Lam, T., Olsen, A., Larney, S., Dietze, P., & Nielsen, S. (2022). Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply. International Journal of Drug Policy, 100, Article 103513.
  90. Turner, S., Mota, N., Bolton, J., & Sareen, J. (2018). Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depression and Anxiety, 35(9), 851-860.
  91. UK Government, Department of Health and Social Care. (2025). Supplying take home naloxone without a prescription.
  92. UK Government, Office for Health Improvement and Disparities. (2025). Local preparedness for synthetic opioids in England.
  93. United Nations Office on Drugs and Crime. (2026). World drug report 2026.
  94. United Nations Office on Drugs and Crime & World Health Organization. (2020). International standards for the treatment of drug use disorders (revised ed.).
  95. United Nations System Chief Executives Board for Coordination. (2018). United Nations system common position supporting the implementation of the international drug control policy through effective inter-agency collaboration.
  96. US Food and Drug Administration. (n.d.). Where and how to dispose of unused medicines.
  97. US Food and Drug Administration. (2016). New safety measures announced for opioid analgesics, prescription opioid cough products, and benzodiazepines.
  98. US Food and Drug Administration. (2019). FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin and pregabalin.
  99. US Food and Drug Administration. (2020). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class.
  100. US Food and Drug Administration. (2023). FDA approves first over-the-counter naloxone nasal spray.
  101. Verheyden, S. L., Hadfield, J., Calin, T., & Curran, H. V. (2002). Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, “ecstasy”) on mood: Evidence of gender differences. Psychopharmacology, 161(1), 23-31.
  102. Volkow, N. D., Wang, G.-J., Fischman, M. W., Foltin, R., Fowler, J. S., Franceschi, D., Franceschi, M., Logan, J., Gatley, S. J., Wong, C., Ding, Y.-S., Hitzemann, R., & Pappas, N. (2000). Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sciences, 67(12), 1507-1515.
  103. Vrolijk, R. Q., Brunt, T. M., Vreeker, A., & Niesink, R. J. M. (2017). Is online information on ecstasy tablet content safe? Addiction, 112(1), 94-100.
  104. Vuori, E., Henry, J. A., Ojanperä, I., Nieminen, R., Savolainen, T., Wahlsten, P., & Jäntti, M. (2003). Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction, 98(3), 365-368.
  105. White, J. M., & Irvine, R. J. (1999). Mechanisms of fatal opioid overdose. Addiction, 94(7), 961-972.
  106. Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013). Regulation of μ-opioid receptors: Desensitization, phosphorylation, internalization, and tolerance. Pharmacological Reviews, 65(1), 223-254.
  107. World Health Organization. (2004). Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users.
  108. World Health Organization. (2014). Community management of opioid overdose.
  109. World Health Organization. (2022). Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations.
  110. World Health Organization. (2025). Opioid overdose [Fact sheet].
  111. World Health Organization. (2026). ICD-11 for mortality and morbidity statistics.
  112. Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., & Gould, T. D. (2018). Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacological Reviews, 70(3), 621-660.

BOOKS FROM OUR SHELF

  1. Szalavitz, M. (2021). Undoing drugs: The untold story of harm reduction and the future of addiction. Hachette Go.

Last reviewed October 2026

This article is general information, not medical advice, and it is not a substitute for emergency care. It cannot tell you whether a drug, an amount or a combination is safe for you, and nothing in it makes any drug safe. Do not start, stop or change a prescribed medicine because of anything written here; talk to whoever prescribed it. Psychological support is intended to work alongside appropriate medical care, never to replace it.

A therapist taking notes on a clipboard during a session

WORKING WITH THIS

When using has started to cost more than it gives

You don’t have to be in crisis to talk to someone about drugs. Maybe you’re worried about how much you use, or you’ve noticed it’s become the way you get through anxiety, low mood or stress, or you’ve tried to cut down and it hasn’t stuck. Those are exactly the conversations we have here, without judgment, alongside whatever medical care you need.

If things have gone further than that, severe dependence, withdrawal and detox need a doctor or a specialist addiction service. If you’re not sure which you need, a doctor can help you decide.

Related Posts